Integrated Nuclear Medicine System Increases Clinical Throughput and Improves Interdepartmental Communication.
By MedImaging International staff writers Posted on 26 Oct 2014 |
New software is designed to meet the specific needs of nuclear medicine, offering a unique way to fully integrate the nuclear medicine or molecular imaging department’s workflow and to optimize interdepartmental communications, using advanced image processing and speech recognition.
Agfa HealthCare (Mortsel, Belgium) will present its Impax for Nuclear Medicine at the 2014 Congress of the European Association of Nuclear Medicine (EANM), held in Gothenburg (Sweden), October 18-22, 2014. Impax for Nuclear Medicine is designed to provide integrated care for the nuclear medicine or molecular imaging department. It provides optimized efficiency, due to a fully automated workflow from order to result. The advanced image processing and speech recognition allow increased clinical throughput. The solution supports improved interdepartmental communication, such as for tumor boards, to increase personalized patient care.
“Integration plays an increasing role in nuclear medicine, with more and more hospitals implementing integrated or combined nuclear medicine systems,” commented Hans Vandewyngaerde, president of Europe, the Middle East, and Africa (EMEA) regions at Agfa HealthCare. “Impax for Nuclear Medicine delivers all the benefits of integrated care to the nuclear medicine department, while supporting the hospital and caregivers in meeting the future integrated care demands of the patient-centric healthcare model.”
Related Links:
Agfa HealthCare
Agfa HealthCare (Mortsel, Belgium) will present its Impax for Nuclear Medicine at the 2014 Congress of the European Association of Nuclear Medicine (EANM), held in Gothenburg (Sweden), October 18-22, 2014. Impax for Nuclear Medicine is designed to provide integrated care for the nuclear medicine or molecular imaging department. It provides optimized efficiency, due to a fully automated workflow from order to result. The advanced image processing and speech recognition allow increased clinical throughput. The solution supports improved interdepartmental communication, such as for tumor boards, to increase personalized patient care.
“Integration plays an increasing role in nuclear medicine, with more and more hospitals implementing integrated or combined nuclear medicine systems,” commented Hans Vandewyngaerde, president of Europe, the Middle East, and Africa (EMEA) regions at Agfa HealthCare. “Impax for Nuclear Medicine delivers all the benefits of integrated care to the nuclear medicine department, while supporting the hospital and caregivers in meeting the future integrated care demands of the patient-centric healthcare model.”
Related Links:
Agfa HealthCare
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease